Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M BERGMAN

Showing results (591-600 of 784) with videos related to

Pageof 79
Sort By:
Elife|December 20, 2019
TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growthSander Al Palit, Daniel Vis, Suzan Stelloo, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2022
Progression-Free Survival and Local Control After SABR for up to 5 Oligometastases: An Analysis From the Population-Based Phase 2 SABR-5 TrialSarah Baker, Will Jiang, Benjamin Mou, et al.
Neoplasia (New York, N.Y.)|January 16, 2017
Randomized Phase III Study to Assess Efficacy and Safety of Adjuvant CAPOX with or without Bevacizumab in Patients after Resection of Colorectal Liver Metastases: HEPATICA studyNikol Snoeren, Richard van Hillegersberg, Sander B Schouten, et al.
Cancer Immunology, Immunotherapy : CII|June 15, 2007
An ex vivo readout for evaluation of dendritic cell-induced autologous cytotoxic T lymphocyte responses against esophageal cancerFrancesca Milano, Agnieszka M Rygiel, Navtej Buttar, et al.
Clinical Genitourinary Cancer|October 29, 2017
The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate CancerDaniel Heinrich, Jasmin Bektic, Andries M Bergman, et al.
Glia|April 4, 2022
Survival motor neuron protein deficiency alters microglia reactivityGuzal Khayrullina, Zaida A Alipio-Gloria, Marc-Olivier Deguise, et al.
European Urology Oncology|November 13, 2022
Role of Local and/or Metastasis-directed Therapy in Patients with Hormone-sensitive M1a Prostate Cancer-A Systematic ReviewHilda A de Barros, Isabeau van Beurden, Matteo Droghetti, et al.
Pharmaceutical Research|October 11, 2023
Cortisol as Biomarker for CYP17-Inhibition is Associated with Therapy Outcome of Abiraterone AcetateMaaike A C Bruin, Ma Ida Mohmaed Ali, Merel van Nuland, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2015
The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancerR J van Soest, A J M Nieuweboer, E S de Morrée, et al.
Gastrointestinal Endoscopy|December 2, 2014
Is it justified to ablate flat-type esophageal squamous cancer? An analysis of endoscopic submucosal dissection specimens of lesions meeting the selection criteria of radiofrequency studiesMarnix Jansen, Dirk W Schölvinck, Ryoji Kushima, et al.
Pageof 79

Showing results (591-600 of 784) with videos related to

Sort By:
Pageof 79
Elife|December 20, 2019
TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growthSander Al Palit, Daniel Vis, Suzan Stelloo, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2022
Progression-Free Survival and Local Control After SABR for up to 5 Oligometastases: An Analysis From the Population-Based Phase 2 SABR-5 TrialSarah Baker, Will Jiang, Benjamin Mou, et al.
Neoplasia (New York, N.Y.)|January 16, 2017
Randomized Phase III Study to Assess Efficacy and Safety of Adjuvant CAPOX with or without Bevacizumab in Patients after Resection of Colorectal Liver Metastases: HEPATICA studyNikol Snoeren, Richard van Hillegersberg, Sander B Schouten, et al.
Cancer Immunology, Immunotherapy : CII|June 15, 2007
An ex vivo readout for evaluation of dendritic cell-induced autologous cytotoxic T lymphocyte responses against esophageal cancerFrancesca Milano, Agnieszka M Rygiel, Navtej Buttar, et al.
Clinical Genitourinary Cancer|October 29, 2017
The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate CancerDaniel Heinrich, Jasmin Bektic, Andries M Bergman, et al.
Glia|April 4, 2022
Survival motor neuron protein deficiency alters microglia reactivityGuzal Khayrullina, Zaida A Alipio-Gloria, Marc-Olivier Deguise, et al.
European Urology Oncology|November 13, 2022
Role of Local and/or Metastasis-directed Therapy in Patients with Hormone-sensitive M1a Prostate Cancer-A Systematic ReviewHilda A de Barros, Isabeau van Beurden, Matteo Droghetti, et al.
Pharmaceutical Research|October 11, 2023
Cortisol as Biomarker for CYP17-Inhibition is Associated with Therapy Outcome of Abiraterone AcetateMaaike A C Bruin, Ma Ida Mohmaed Ali, Merel van Nuland, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2015
The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancerR J van Soest, A J M Nieuweboer, E S de Morrée, et al.
Gastrointestinal Endoscopy|December 2, 2014
Is it justified to ablate flat-type esophageal squamous cancer? An analysis of endoscopic submucosal dissection specimens of lesions meeting the selection criteria of radiofrequency studiesMarnix Jansen, Dirk W Schölvinck, Ryoji Kushima, et al.
Pageof 79